...
首页> 外文期刊>Inorganica Chimica Acta >Cobalt (II), zirconium(IV), calcium(II) complexes with dipicolinic acid and imidazole derivatives: X-ray studies, thermal analyses, evaluation as in vitro antibacterial and cytotoxic agents
【24h】

Cobalt (II), zirconium(IV), calcium(II) complexes with dipicolinic acid and imidazole derivatives: X-ray studies, thermal analyses, evaluation as in vitro antibacterial and cytotoxic agents

机译:钴(II),锆(IV),钙(II)配合物与二辛溶胶和咪唑衍生物:X射线研究,热分析,评价为体外抗菌和细胞毒剂

获取原文
获取原文并翻译 | 示例
           

摘要

Four coordination complexes, [2-mimH](2)[Co(pydc)(2)][ClO4]center dot H2O (1), [2-mimH](2)[Zr(pydc)(3)] (2), [imiH](2) [Zr(pydc)(3)]center dot 4H(2)O (3) and [Ca(pydcH(2))(2)(H2O)](2)[Co(pydc)(2)](2)center dot 6H(2)O (4) have been prepared from the reaction between proton-transfer compounds containing pyridine-2,6-dicarboxylic acid (pydcH(2)) with 2-methylimidazole (2-mim) and imidazole (imi) in 1:2 M ratio and metal salts. These compounds have been characterized by spectroscopic methods and single crystal X-ray diffraction technique was used to determine their structures. Also, thermal analyses (TGA/DTA) were carried out on all the synthetic compounds. Then the agar dilution and diffusion methods were used to determine the antibacterial activity of the ligands and their complexes on the growth profile of two pathogenic Gram-positive bacteria namely Staphylococcus aureus and Bacillus cereus and also two Gram-negative bacteria namely Escherichia coli and Klebsiella oxytoca. The highest antibacterial activity was exhibited by (pydcH(2)) and complex (2) at MIC values between 75 and 175 mu g/mL. These two compounds exhibited stronger effects than gentamicin as a standard drug toward Klebsiella oxytoca. The anti-proliferative activity of compounds was evaluated in vitro using oxaliplatin as a positive control against MCF7 (a human breast cancer), HL60 (a human lymphocyte) and HT29 (a human colon adenocarcinoma) cell lines. Selective and significant cytotoxic effect of complex (4) was observed on MCF7 cells (IC50 = 10 mu M, Cell viability 62.12%). (C) 2018 Elsevier B.V. All rights reserved.
机译:四个配位复合物,[2-mimH](2)[CO(PYDC)(2)] [CLO4]中心点H 2 O(1),[2-MIMH](2)[ZR(PYDC)(3)](2 ),[IMIH](2)[Zr(PyDC)(3)]中心点4h(2)O(3)和[Ca(2))(2)(2)(H2O)](2)[Co(PyDC (2)](2)中心点6h(2)O(4)已由含有吡啶-2,6-二羧酸(PydCH(2))的质子转移化合物之间的反应制备,其中2-甲基咪唑(2 -mim)和咪唑(IMI)在1:2 m的比例和金属盐中。这些化合物的特征在于光谱法,使用单晶X射线衍射技术来确定它们的结构。此外,在所有合成化合物上进行热分析(TGA / DTA)。然后使用琼脂稀释和扩散方法来确定配体的抗菌活性及其复合物对两种致病革兰氏阳性细菌的生长分布,即金黄色葡萄球菌和芽孢杆菌和芽孢杆菌和芽孢杆菌和Klebsiella ocktoca的两个革兰氏阴性细菌。在75-175μmg/ ml之间的MIC值下(PydCH(2))和复合物(2)显示最高的抗菌活性。这两种化合物表现出比庆大霉素的更强的效果,作为氧化克雷布氏菌的标准药物。使用Oxaliplatin作为针对MCF7(人乳腺癌),HL60(人淋巴细胞)和HT29(人结肠腺癌)细胞系的阳性对照进行体外进行化合物的抗增殖活性。在MCF7细胞上观察到复合物(4)的选择性和显着的细胞毒性作用(IC50 =10μm,细胞活力62.12%)。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号